Literature DB >> 18978308

Altered {beta}-catenin accumulation in hepatocellular carcinomas of diethylnitrosamine-exposed rhesus macaques.

Bih-Rong Wei1, Jennifer B Edwards, Shelley B Hoover, Heather S Tillman, L Tiffany Reed, Robert C Sills, R Mark Simpson.   

Abstract

Chemical exposures are important risks for development of hepatocellular carcinoma (HCC). One such chemical, diethylnitrosamine (DENA), is present in food products as well as in industrial and research settings. Further examination of tumors induced by DENA may yield clues to human risk. HCC from seven rhesus macaques exposed to DENA was selected from a tissue archive to examine for evidence of Wnt/beta-catenin signaling events, which are frequently associated with HCC. DENA exposure durations ranged from 8 to 207 months, and total accumulated dose ranged from 0.7 to 4.08 mg. Unexposed colony breeder macaques served as controls. Previously unrecognized HCC metastases were discovered in lungs of three macaques. Overexpression of beta-catenin and glutamine synthetase was detected by immunohistochemistry in six confirmed primary HCC and all metastatic HCC, which implicated Wnt/beta-catenin activation. Concomitant beta-catenin gene mutation was detected in one primary HCC; similar findings have been reported in human and rodent HCC. Neither beta-catenin mutation nor beta-catenin overexpression appeared to influence metastatic potential. Accumulation of intracellular proteins involved in Wnt/beta-catenin signaling during HCC oncogenesis in rhesus macaques exposed to DENA appears to include other mechanisms, in addition to mutation of beta-catenin gene.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18978308      PMCID: PMC3855431          DOI: 10.1177/0192623308327120

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  31 in total

Review 1.  Cancer burden in the year 2000. The global picture.

Authors:  D M Parkin; F I Bray; S S Devesa
Journal:  Eur J Cancer       Date:  2001-10       Impact factor: 9.162

2.  IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans: some N-nitroso compounds.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risk Chem Man       Date:  1978-05

3.  Close correlation between beta-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinomas.

Authors:  B Terris; P Pineau; L Bregeaud; D Valla; J Belghiti; P Tiollais; C Degott; A Dejean
Journal:  Oncogene       Date:  1999-11-11       Impact factor: 9.867

4.  Human and mouse hepatocellular adenoma and carcinoma display similar tumorigenesis pathway alterations.

Authors:  Jessica Zucman-Rossi
Journal:  J Hepatol       Date:  2008-02-14       Impact factor: 25.083

5.  Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors.

Authors:  H Aydinlik; T D Nguyen; O Moennikes; A Buchmann; M Schwarz
Journal:  Oncogene       Date:  2001-11-22       Impact factor: 9.867

6.  Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration samples.

Authors:  Momin T Siddiqui; M Hossein Saboorian; S Tunc Gokaslan; Raheela Ashfaq
Journal:  Cancer       Date:  2002-02-25       Impact factor: 6.860

7.  Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse.

Authors:  S D Vesselinovitch; N Mihailovich
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

Review 8.  Caught up in a Wnt storm: Wnt signaling in cancer.

Authors:  Rachel H Giles; Johan H van Es; Hans Clevers
Journal:  Biochim Biophys Acta       Date:  2003-06-05

9.  Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice.

Authors:  Diego F Calvisi; Valentina M Factor; Sara Ladu; Elizabeth A Conner; Snorri S Thorgeirsson
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

10.  Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital.

Authors:  Diego F Calvisi; Sara Ladu; Valentina M Factor; Snorri S Thorgeirsson
Journal:  Carcinogenesis       Date:  2004-01-23       Impact factor: 4.944

View more
  2 in total

1.  Sorafenib effect on liver neoplastic changes in rats: more than a kinase inhibitor.

Authors:  Nahla E El-Ashmawy; Eman G Khedr; Hoda A El-Bahrawy; Eslam E Abd El-Fattah
Journal:  Clin Exp Med       Date:  2016-04-16       Impact factor: 3.984

2.  Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients.

Authors:  Bih-Rong Wei; Shelley B Hoover; Mark M Ross; Weidong Zhou; Francesco Meani; Jennifer B Edwards; Elizabeth I Spehalski; John I Risinger; W Gregory Alvord; Octavio A Quiñones; Claudio Belluco; Luca Martella; Elio Campagnutta; Antonella Ravaggi; Ren-Ming Dai; Paul K Goldsmith; Kevin D Woolard; Sergio Pecorelli; Lance A Liotta; Emanuel F Petricoin; R Mark Simpson
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.